FDA Approves Oxbryta for Treatment of Sickle Cell Disease

TUESDAY, Nov. 26, 2019 -- Oxbryta (voxelotor) has been granted accelerated approval for the treatment of sickle cell disease in patients ages 12 years and older, the U.S. Food and Drug Administration announced Monday. Oxbryta is the first approved...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news